What Covid-19 Taught Us About Speedy and Safe Rx Approval Pathways and Predictable Pricing

What Covid-19 Taught Us About Speedy and Safe Rx Approval Pathways and Predictable Pricing

Can the Vaccine Rollout Guide Us to More Efficient Health Care?

See this article as it originally appeared in Inc.

What the Covid vaccine taught us, and how we can be better.

With Covid-19 vaccine progress ahead of targets, it’s clear that the pharmaceutical industry has come through in a big way when the country needed it most. The vaccines were developed, approved, and distributed on a larger scale and faster than any other vaccine or medicine in history. Perhaps this experience could open our minds to a more efficient future for the U.S. health care system.

Review process for drugs can be both swift and safe.

Under normal conditions, it takes new drugs an average of 12 years to navigate the approval process and get to market. Everyone agrees the process should be thorough to ensure drugs are safe and effective. The fast-track and breakthrough approval pathways improve the approval timeline. But couldn’t the overall system be faster?

The Covid-19 vaccines showed how fast this process can move. Emergency Use Authorization (EUA) and a guaranteed buyer in the U.S. government sped up the process, but studies and trials were conducted to the same high standard of every other drug.

Now that we’ve seen the review system’s top speed, surely we can quicken the average. Doing so would dramatically decrease pharmaceutical costs and get life-saving and life-changing new medications to people who desperately need them.

Featured Company
Focus Areas
  • Reducing Pharmacy Costs
Experts In This Article

Nick McLaughlin
CEO, Breeze

Featuring Solutions For
Custom CTA designs for this insight
Get the latest digital download or fill out our contact form to talk to an expert about this type of content. This module is optional and meant to allow Insight pages to act as landing pages when appropriate contact form
Related Insights
Break up with the status quo

We’re igniting real change. From building and accelerating revolutionary healthcare businesses to delivering transformative tech and services to our clients, we’re raising the bar of what healthcare can be.

Ready to join us?